BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36810119)

  • 21. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy.
    Kao CH; Tsai SC; Wang JJ; Ho YJ; Yen RF; Ho ST
    Cancer; 2001 Jul; 92(2):434-9. PubMed ID: 11466699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Time-Phase Effect on 18F-FDG PET/CT Delineation Methods for Treatment Planning of Nasopharyngeal Carcinoma.
    Chen YZ; Li WF; Wang JY; Wang JM; Ou RY; Zheng XW; Xu YS; Zhao L
    Clin Nucl Med; 2016 May; 41(5):354-61. PubMed ID: 26859212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
    Wei J; Pei S; Zhu X
    Oral Oncol; 2016 Jan; 52():11-7. PubMed ID: 26547126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
    Lee YJ; Kim YM; Jung PS; Lee JJ; Kim JK; Kim YT; Nam JH
    J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging.
    Chan SC; Ng SH; Chang JT; Lin CY; Chen YC; Chang YC; Hsu CL; Wang HM; Liao CT; Yen TC
    Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1032-40. PubMed ID: 16622711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reflecting on the utility of standardized uptake values on
    Qiu X; Wu H; Xu T; Xie S; You Z; Hu Y; Zheng Y; Liang Z; Huang C; Yi L; Li L; Liu J; Fei Z; Chen C
    BMC Cancer; 2022 May; 22(1):495. PubMed ID: 35513804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emission tomography.
    Kao CH; Shiau YC; Shen YY; Yen RF
    Cancer; 2002 Apr; 94(7):1981-6. PubMed ID: 11932900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic tumor volume and conformal radiotherapy based on prognostic PET/CT for treatment of nasopharyngeal carcinoma.
    Fei Z; Chen C; Huang Y; Qiu X; Li Y; Li L; Chen T
    Medicine (Baltimore); 2019 Jul; 98(28):e16327. PubMed ID: 31305420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-body
    Ren YY; Li YC; Wu HB; Wang QS; Han YJ; Zhou WL; Li HS
    Eur J Radiol; 2017 Apr; 89():200-207. PubMed ID: 28267540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
    Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
    J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET/CT standardized uptake value and EGFR expression predicts treatment failure in nasopharyngeal carcinoma.
    Fei Z; Xu T; Hong H; Xu Y; Chen J; Qiu X; Ding J; Huang C; Li L; Liu J; Chen C
    Radiat Oncol; 2023 Feb; 18(1):33. PubMed ID: 36814303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of diffusion-weighted MR imaging and
    Schroeder C; Lee JH; Tetzner U; Seidel S; Kim SY
    Eur J Radiol; 2020 Sep; 130():109157. PubMed ID: 32652403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas.
    Lee SW; Nam SY; Im KC; Kim JS; Choi EK; Ahn SD; Park SH; Kim SY; Lee BJ; Kim JH
    Radiother Oncol; 2008 May; 87(2):211-6. PubMed ID: 18237806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The valuable role of dynamic
    Huang X; Zhuang M; Yang S; Wang Y; Liu Q; Xu X; Xiao M; Peng Y; Jiang P; Xu W; Guo S; Wang R; Wei W; Zhong G; Zhou Y; Peng S; Li X; Cui J; Wang S; Zhang Y; Liu Z
    Radiother Oncol; 2023 Feb; 179():109440. PubMed ID: 36566989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
    Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
    J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Petrović J; Beatović S; Šobić-Šaranović D; Odalović S; Stojiljković M; Grozdic-Milojevic I; Veljkovic M; Jovanovic D; Artiko V
    Hell J Nucl Med; 2022; 25(1):19-25. PubMed ID: 35388800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.